Animal models for bullous pemphigoid

Grant James Anhalt, Luis A. Diaz

Research output: Contribution to journalArticle

Abstract

There has been a great deal of speculation (and experimentation) about the precise pathogenic role of bullous pemphigoid autoantibodies since their demonstration in 1964 by Beutner and Jordon1 and Jordon et al. in 1967,2 although there is considerable evidence that the autoantibodies are in fact responsible for the cutaneous lesions and are not just and epiphenomenon that has yet to be established beyond doubt. One of the reasons that there are still some questions rests with the fact that there is not a simple, reproducible animal model for production of the cutaneous lesions of BP in vivo, either by systemic passive transfer of the human autoantibodies or by immunization of animals with the BP antigen(s). Some studies have come very close to achieving this goal but have not succeeded entirely. The details of these studies, current thoughts on why these studies have not been successful as yet, and future directions for the definition of this problem are discussed in this chapter.

Original languageEnglish (US)
Pages (from-to)117-125
Number of pages9
JournalClinics in Dermatology
Volume5
Issue number1
DOIs
StatePublished - 1987

Fingerprint

Bullous Pemphigoid
Autoantibodies
Animal Models
Skin
Immunization
Antigens

ASJC Scopus subject areas

  • Dermatology

Cite this

Animal models for bullous pemphigoid. / Anhalt, Grant James; Diaz, Luis A.

In: Clinics in Dermatology, Vol. 5, No. 1, 1987, p. 117-125.

Research output: Contribution to journalArticle

Anhalt, Grant James ; Diaz, Luis A. / Animal models for bullous pemphigoid. In: Clinics in Dermatology. 1987 ; Vol. 5, No. 1. pp. 117-125.
@article{c8fe38ef7c18499e95a370b4a52e6347,
title = "Animal models for bullous pemphigoid",
abstract = "There has been a great deal of speculation (and experimentation) about the precise pathogenic role of bullous pemphigoid autoantibodies since their demonstration in 1964 by Beutner and Jordon1 and Jordon et al. in 1967,2 although there is considerable evidence that the autoantibodies are in fact responsible for the cutaneous lesions and are not just and epiphenomenon that has yet to be established beyond doubt. One of the reasons that there are still some questions rests with the fact that there is not a simple, reproducible animal model for production of the cutaneous lesions of BP in vivo, either by systemic passive transfer of the human autoantibodies or by immunization of animals with the BP antigen(s). Some studies have come very close to achieving this goal but have not succeeded entirely. The details of these studies, current thoughts on why these studies have not been successful as yet, and future directions for the definition of this problem are discussed in this chapter.",
author = "Anhalt, {Grant James} and Diaz, {Luis A.}",
year = "1987",
doi = "10.1016/0738-081X(87)90056-3",
language = "English (US)",
volume = "5",
pages = "117--125",
journal = "Clinics in Dermatology",
issn = "0738-081X",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Animal models for bullous pemphigoid

AU - Anhalt, Grant James

AU - Diaz, Luis A.

PY - 1987

Y1 - 1987

N2 - There has been a great deal of speculation (and experimentation) about the precise pathogenic role of bullous pemphigoid autoantibodies since their demonstration in 1964 by Beutner and Jordon1 and Jordon et al. in 1967,2 although there is considerable evidence that the autoantibodies are in fact responsible for the cutaneous lesions and are not just and epiphenomenon that has yet to be established beyond doubt. One of the reasons that there are still some questions rests with the fact that there is not a simple, reproducible animal model for production of the cutaneous lesions of BP in vivo, either by systemic passive transfer of the human autoantibodies or by immunization of animals with the BP antigen(s). Some studies have come very close to achieving this goal but have not succeeded entirely. The details of these studies, current thoughts on why these studies have not been successful as yet, and future directions for the definition of this problem are discussed in this chapter.

AB - There has been a great deal of speculation (and experimentation) about the precise pathogenic role of bullous pemphigoid autoantibodies since their demonstration in 1964 by Beutner and Jordon1 and Jordon et al. in 1967,2 although there is considerable evidence that the autoantibodies are in fact responsible for the cutaneous lesions and are not just and epiphenomenon that has yet to be established beyond doubt. One of the reasons that there are still some questions rests with the fact that there is not a simple, reproducible animal model for production of the cutaneous lesions of BP in vivo, either by systemic passive transfer of the human autoantibodies or by immunization of animals with the BP antigen(s). Some studies have come very close to achieving this goal but have not succeeded entirely. The details of these studies, current thoughts on why these studies have not been successful as yet, and future directions for the definition of this problem are discussed in this chapter.

UR - http://www.scopus.com/inward/record.url?scp=0023063728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023063728&partnerID=8YFLogxK

U2 - 10.1016/0738-081X(87)90056-3

DO - 10.1016/0738-081X(87)90056-3

M3 - Article

C2 - 3552181

AN - SCOPUS:0023063728

VL - 5

SP - 117

EP - 125

JO - Clinics in Dermatology

JF - Clinics in Dermatology

SN - 0738-081X

IS - 1

ER -